Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.63 |
| ▸ | CA1 | P00915 | 1/20 | 0.63 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.52 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6251202 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| SCHEMBL3861238 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| SCHEMBL7204823 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| SCHEMBL3855790 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| SCHEMBL7212250 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1672036 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| SCHEMBL276768 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| SCHEMBL490747 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| SCHEMBL3452084 | 1.00 | CA2 (0.63) | CA2CA1GRIK1GRIK2SLC1A2 | |
| Hydrochloric Acid SCHEMBL25419337 | 0.98 | CA2 (0.61) | CA2CA1GRIK1GRIK2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6605638-B1 | Treating multidrug resistant tumors; increasing drug bioavailability | D-PHARM LIMITED (IL) | 2003-08-12 | — | — | US | claimed |
| US-11993600-B2 | Saturated spirocyclics as antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| WO-2023107419-A1 | SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-20230174531-A1 | SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2023-06-08 | — | — | US | disclosed |
| EP-4175941-A2 | METHODS FOR SEPARATION AND RECOVERY OF RARE EARTH ELEMENTS FROM AQUEOUS SOLUTIONS USING DIGLYCOLAMIDE DERIVATIVES | UT-Battelle, LLC (US) | 2023-05-10 | — | — | EP | disclosed |
| US-6605638-B1 | Treating multidrug resistant tumors; increasing drug bioavailability | D-PHARM LIMITED (IL) | 2003-08-12 | — | — | US | disclosed |
| EP-0912465-A1 | IMPROVED LITHIUM AND AMINE DISSOLVING METAL REDUCTION | Allergan Sales, Inc. (US) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998003451-A1 | IMPROVED LITHIUM AND AMINE DISSOLVING METAL REDUCTION | ALLERGAN SALES, INC. (US) | 1998-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11993600-B2 | Saturated spirocyclics as antiviral agents | ACE, ACE2, PKD1 | CA2 1149/4885CA1 3044/4885GRIK1 2556/4885 |
| US-20230174531-A1 | SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS | ACE, ACE2, PKD1 | CA2 1149/4885CA1 3044/4885GRIK1 2556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.